TCIM
CMD

TIAA CREF Investment Management’s Cantel Medical Corporation CMD Stock Holding History

TIAA CREF Investment Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$4.4M Sell
65,739
-40,014
-38% -$3.03M ﹤0.01% 1534
2018
Q4 		$7.87M Sell
105,753
-45,725
-30% -$3.78M 0.01% 1076
2018
Q3 		$13.9M Buy
151,478
+50,294
+50% +$4.79M 0.01% 934
2018
Q2 		$9.95M Sell
101,184
-17,269
-15% -$1.93M 0.01% 1158
2018
Q1 		$13.2M Sell
118,453
-24,428
-17% -$2.74M 0.01% 958
2017
Q4 		$14.7M Buy
142,881
+16,465
+13% +$1.64M 0.01% 925
2017
Q3 		$11.9M Sell
126,416
-20,076
-14% -$1.58M 0.01% 1042
2017
Q2 		$11.4M Buy
146,492
+834
+0.6% +$62.6K 0.01% 1055
2017
Q1 		$11.7M Sell
145,658
-5,649
-4% -$449K 0.01% 1020
2016
Q4 		$11.9M Sell
151,307
-7,360
-5% -$572K 0.01% 1013
2016
Q3 		$12.4K Sell
158,667
-588
-0.4% -$42.7K 0.01% 995
2016
Q2 		$10.9M Buy
159,255
+3,100
+2% +$214K 0.01% 1018
2016
Q1 		$11.1M Buy
156,155
+14,954
+11% +$939K 0.01% 999
2015
Q4 		$8.77M Sell
141,201
-4,046
-3% -$247K 0.01% 1148
2015
Q3 		$8.24M Sell
145,247
-13,990
-9% -$741K 0.01% 1173
2015
Q2 		$8.55M Sell
159,237
-2,280
-1% -$111K 0.01% 1271
2015
Q1 		$7.67M Buy
161,517
+9,493
+6% +$420K 0.01% 1334
2014
Q4 		$6.58M Sell
152,024
-7,649
-5% -$312K ﹤0.01% 1429
2014
Q3 		$5.49M Sell
159,673
-2,883
-2% -$102K ﹤0.01% 1540
2014
Q2 		$5.95M Buy
162,556
+561
+0.3% +$19K ﹤0.01% 1552
2014
Q1 		$5.46M Sell
161,995
-2,230
-1% -$73.6K ﹤0.01% 1551
2013
Q4 		$5.57M Sell
164,225
-1,180
-0.7% -$40.9K ﹤0.01% 1564
2013
Q3 		$5.27M Sell
165,405
-3,153
-2% -$83.9K ﹤0.01% 1549
2013
Q2 		$3.81M Buy
+168,558
New +$3.65M ﹤0.01% 1727

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

TIAA CREF Investment Management's CMD Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Cantel Medical Corporation (CMD) stake by 38% in Q1 2019, selling an estimated $3.03M and leaving 65,739 shares worth $4.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1534.

TIAA CREF Investment Management first reported a position in CMD in Q2 2013 and has held it in 24 quarters since. The position peaked at $14.7M in Q4 2017. 254 funds tracked by Wall St. Rank hold CMD as of Q1 2019.

  • TIAA CREF Investment Management held 65,739 shares of Cantel Medical Corporation worth $4.4M as of Q1 2019.
  • TIAA CREF Investment Management sold 40,014 Cantel Medical Corporation shares in Q1 2019, an estimated $3.03M.
  • Cantel Medical Corporation made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1534 holding.
  • TIAA CREF Investment Management first reported a position in Cantel Medical Corporation in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Cantel Medical Corporation position peaked at $14.7M in Q4 2017.
  • 254 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.